| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/23/2002 | EP1173591A2 Pesticidal fusions |
| 01/23/2002 | EP1173590A2 Zymogen activation system |
| 01/23/2002 | EP1173589A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
| 01/23/2002 | EP1173588A1 Nucleic acid molecule, containing a nucleic acid which codes for a polypeptide with chorismate mutase activity |
| 01/23/2002 | EP1173587A1 Dsp-10 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173586A1 Dsp-8 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173585A1 Epoxide hydrolases of aspergillus origin |
| 01/23/2002 | EP1173584A2 Methods for producing plants with elevated oleic acid content |
| 01/23/2002 | EP1173583A1 Plant acyltransferases |
| 01/23/2002 | EP1173582A1 Herbicide resistant plants |
| 01/23/2002 | EP1173581A1 Herbicide resistant plants |
| 01/23/2002 | EP1173580A1 Herbicide resistant plants |
| 01/23/2002 | EP1173579A1 Carotene hydroxylase and method for producing xanthophyll derivatives |
| 01/23/2002 | EP1173578A2 Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants |
| 01/23/2002 | EP1173577A2 Prevention, diagnosis and treatment of lyme disease |
| 01/23/2002 | EP1173576A1 A strain suitable for producing a live, orally applicable escherichia coli vaccine for the prevention of postweaning diarrhoea in pigs, and the procedure suitable for producing that strain |
| 01/23/2002 | EP1173575A2 Maize npr1 polynucleotides and methods of use |
| 01/23/2002 | EP1173574A1 Splicing factor |
| 01/23/2002 | EP1173573A1 Method for down-regulating il5 activity |
| 01/23/2002 | EP1173571A2 Human ion channel proteins |
| 01/23/2002 | EP1173570A2 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma |
| 01/23/2002 | EP1173569A1 Synthetic signalling molecules |
| 01/23/2002 | EP1173568A2 Laminin 2 and methods for its use |
| 01/23/2002 | EP1173567A2 Tribonectins |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173565A1 Adipocyte complement related protein homolog zacrp3 |
| 01/23/2002 | EP1173564A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension |
| 01/23/2002 | EP1173563A1 Compositions and methods for the treatment of tumour |
| 01/23/2002 | EP1173562A2 Inhibition of histone deacetylase |
| 01/23/2002 | EP1173561A2 Non-invasive method for detecting target rna |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173559A1 Process for nucleic acid purification using silicon carbide |
| 01/23/2002 | EP1173556A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such |
| 01/23/2002 | EP1173555A1 Method and kit for indicating the level of bad breath |
| 01/23/2002 | EP1173554A2 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 01/23/2002 | EP1173553A2 Transgenic plant resistant to mycotoxins and methods |
| 01/23/2002 | EP1173552A2 Carbohydrate-modifying enzymes |
| 01/23/2002 | EP1173551A2 Pseudotyped retroviral vector for gene therapy of cancer |
| 01/23/2002 | EP1173547A2 Dwf4 polynucleotides, polypeptides and uses thereof |
| 01/23/2002 | EP1173546A1 A (bacillus) protein production cell |
| 01/23/2002 | EP1173543A1 A method for altering the metabolism of a plant |
| 01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
| 01/23/2002 | EP1173484A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 01/23/2002 | EP1173483A1 Acrp30r1m, a homolog of acrp30 |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173475A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 01/23/2002 | EP1173474A1 Membrane disruptive peptides covalently oligomerized |
| 01/23/2002 | EP1173465A1 Novel human voltage-gated potassium channel |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173461A1 50 human secreted proteins |
| 01/23/2002 | EP1173460A1 Compositions and methods for use in recombinational cloning of nucleic acids |
| 01/23/2002 | EP1173459A1 Codeinone reductase from alkaloid poppy |
| 01/23/2002 | EP1173458A1 Antisense modulation of sra expression |
| 01/23/2002 | EP1173456A1 Secreted proteins and nucleic acids encoding them |
| 01/23/2002 | EP1173284A1 Homogenising of small-volume mixtures by centrifugation and heating |
| 01/23/2002 | EP1173224A1 Polyethyleneimine:dna formulations for aerosol delivery |
| 01/23/2002 | EP1173204A1 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/23/2002 | EP1056856B1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 01/23/2002 | EP1049744B1 Asymmetric cyanine dye quenchers |
| 01/23/2002 | EP1017789A4 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| 01/23/2002 | EP0968303A4 Method and system for performing a binding assay |
| 01/23/2002 | EP0968275A4 Method and apparatus for treating materials with electrical fields having varying orientations |
| 01/23/2002 | EP0938564B1 Disease resistance in vitis |
| 01/23/2002 | EP0888545B1 Super-paramagnetic particles with increased r 1 relaxivity, processes for producing said particles and use thereof |
| 01/23/2002 | EP0884947A4 Dna vaccination for induction of suppressive t cell response |
| 01/23/2002 | EP0846124B1 Chemical, biochemical and biological processing in thin films |
| 01/23/2002 | EP0840802B1 Method of sequencing by oligomer hybridisation |
| 01/23/2002 | EP0813539A4 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 01/23/2002 | EP0784421B1 Pest trap plants and crop protection |
| 01/23/2002 | EP0700445B1 Stress proteins and uses therefor |
| 01/23/2002 | EP0696205B1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 01/23/2002 | CN1332805A Multiplex amplification of short tandem repeat loci |
| 01/23/2002 | CN1332804A Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 01/23/2002 | CN1332803A Streptococcus antigens |
| 01/23/2002 | CN1332802A Production of recombinant monellin using methylotrophic yeast expression system |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332800A Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 01/23/2002 | CN1332799A Cancer cell vaccine |
| 01/23/2002 | CN1332798A Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis |
| 01/23/2002 | CN1332797A Bleaching enzymes and detergent compositions comprising them |
| 01/23/2002 | CN1332748A Isolated nucleic acid molecules which encodt T cell inducible factors (TIFs), proteins encoded, and uses thereof |
| 01/23/2002 | CN1332249A Process for production of 2-ketone-L-gulonic acid |
| 01/23/2002 | CN1332248A Cattle enteropeptidase catalyzing subunit gene and its gene engineering production process |
| 01/23/2002 | CN1332247A Expression vector containing coding expansion enzyme DNA and host cell for its transformation |
| 01/23/2002 | CN1332246A Corn individual PV-IMGT 32 (NK 603) and composition and method for detecting it |
| 01/23/2002 | CN1332245A Morbillivirus L4 strain fusion protein gene |
| 01/23/2002 | CN1332244A Morbillivirus L4 strain hemagglutinin gene |
| 01/23/2002 | CN1332240A Superoxide dismutase-4 |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/23/2002 | CN1078248C Insulin-secreting cell lines, methods of production and use |
| 01/23/2002 | CN1078042C Method for production of proteins in plant fluids |
| 01/22/2002 | US6340783 Infusing a proteoglycan with a beta-amyloid protein into brain tissue of rodents; allow the proteins to be co-deposited and detect amyloid deposits in the brain tissue using standard staining method for fibrillar amyloid |
| 01/22/2002 | US6340754 Phosphorus containing cyclic nucleotides |
| 01/22/2002 | US6340748 A high level promoter derived from tomato; for genetic engineering, for large scale expression in tomato fruit |
| 01/22/2002 | US6340743 Antibody ligands for specific binding to stalk of polymeric immunoglobulin receptor of cell with proviso that ligand does not bind to secretory component of receptor |
| 01/22/2002 | US6340741 A chimeric protein with a dna binding tetracycline repressor fused to two eukaryotic transcriptional repression domains, a tetracycline inducer that binds the repressor and activates expression in an autoregulatory positive feedback loop |
| 01/22/2002 | US6340740 An isolated polypeptide involved in modulating apoptotis; therapy for acquired immunodeficiency syndrome (aids), nervous system disorders and ischemic injury |
| 01/22/2002 | US6340674 Contacting cancer cells in vivo with an effective amount of an oligonucleotide substantially complementary to a region of igf-1 receptor rna and which specifically hybridizes to igf-1 receptor rna |